CRISPR in Drug Discovery 2023 – ELRIG

If you are attending ELRIG UK’s CRISPR in Drug Discovery 2023, 7-8 February in Oxford, UK, look out for Katharina Montag, author of our scientific poster:

CRISPR/Cas9 as integrative tools in neurological disease models and drug screening platforms

Atf Nagbou from Business Development, would also be pleased to meet you to discuss our range of drug discovery solutions.

If you would like to book a meeting with Katharina and Atf, please send a mail to

Scroll to Top